Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. RNG
7. SPY
8. UNP
9. GOOGL
10. DGX

Go back to Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases
EVOGENE LTD. (NASDAQ: EVGN) Delayed: 0.54 --0 (-0%)
Previous Close $0.54    52 Week High $9.32 
Open $0.56    52 Week Low $5.79 
Day High $0.56    P/E N/A 
Day Low $0.53    EPS $0.00 
Volume 30,934       

EVOGENE LTD. (NASDAQ: EVGN) Delayed: 0.54 --0 (-0%)
Previous Close $0.54    52 Week High $9.32 
Open $0.56    52 Week Low $5.79 
Day High $0.56    P/E N/A 
Day Low $0.53    EPS $0.00 
Volume 30,934